Preferred Label : Carboplatin/Durvalumab/Pemetrexed/Tremelimumab Regimen;
NCIt synonyms : Tremelimumab/Durvalumab/Pemetrexed/Carboplatin; Imjudo/Imfinzi Plus Carboplatin/Pemetrexed; Carboplatin-Durvalumab-Pemetrexed-Tremelimumab; Carboplatin/Imjudo/Pemetrexed/Imfinzi; Carboplatin/Durvalumab/Pemetrexed/Tremelimumab; Carboplatin/Durvalumab/Pemetrexed/Tremelimumab-actl;
NCIt definition : A regimen consisting of carboplatin, durvalumab, pemetrexed and tremelimumab that
may be used in the treatment of non-small cell lung cancer (NSCLC).;
NCI Metathesaurus CUI : CL1922503;
Origin ID : C203686;
UMLS CUI : C5909398;
Semantic type(s)
chemotherapy_regimen_has_component
concept_is_in_subset